Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes

The main objective of the study was to develop an alternative non-genetic rat model for type 2 diabetes (T2D). Six-week-old male Sprague-Dawley rats (190.56±23.60 g) were randomly divided into six groups, namely: Normal Control (NC), Diabetic Control (DBC), Fructose-10 (FR10), Fructose-20 (FR20), Fr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmacological reports Ročník 64; číslo 1; s. 129 - 139
Hlavní autoři: Wilson, Rachel D., Islam, Md. Shahidul
Médium: Journal Article
Jazyk:angličtina
Vydáno: Cham Elsevier Urban & Partner Sp. z o.o 01.01.2012
Springer International Publishing
Témata:
animal model
Animals
Blood Glucose - metabolism
Diabetes Mellitus, Experimental - blood
Diabetes Mellitus, Experimental - chemically induced
Diabetes Mellitus, Experimental - metabolism
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - metabolism
Diet
Disease Models, Animal
Drinking Water
Drug Safety and Pharmacovigilance
Eating
experimental diabetes
fructose
Fructose - administration & dosage
Glucose Tolerance Test - methods
Insulin - blood
Insulin - metabolism
Insulin Resistance - physiology
Insulin-Secreting Cells - metabolism
Lipids - blood
Liver Glycogen - metabolism
Male
Pharmacotherapy
Pharmacy
rat
Rats
Rats, Sprague-Dawley
streptozotocin
type 2 diabetes
fructose
type 2 diabetes
streptozotocin
rat
experimental diabetes
animal model
ISSN:1734-1140, 2299-5684, 2299-5684
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The main objective of the study was to develop an alternative non-genetic rat model for type 2 diabetes (T2D). Six-week-old male Sprague-Dawley rats (190.56±23.60 g) were randomly divided into six groups, namely: Normal Control (NC), Diabetic Control (DBC), Fructose-10 (FR10), Fructose-20 (FR20), Fructose-30 (FR30) and Fructose-40 (FR40) and were fed a normal rat pellet diet ad libitum for 2 weeks. During this period, the two control groups received normal drinking water whilst the fructose groups received 10, 20, 30 and 40% fructose in drinking water ad libitum, respectively. After two weeks of dietary manipulation, all groups except the NC group received a single injection (ip) of streptozotocin (STZ) (40mg/kg b.w.) dissolved in citrate buffer (pH 4.4). The NC group received only a vehicle buffer injection (ip). One week after the STZ injection, animals with non-fasting blood glucose levels > 300mg/dl were considered as diabetic. Three weeks after the STZ injection, the animals in FR20, FR30 and FR40 groups were eliminated from the study due to the severity of diabetes and the FR10 group was selected for the remainder of the 11 weeks experimental period. The significantly (p<0.05) higher fluid intake, blood glucose, serum lipids, liver glycogen, liver function enzymes and insulin resistance (HOMA-IR) and significantly (p<0.05) lower body weight, oral glucose tolerance, number of pancreatic β-cells and pancreatic β-cell functions (HOMA-β) of FR10 group demonstrate that the 10% fructose-fed followed by 40mg/kg of BW STZ injected rat can be a new and alternative model for T2D.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1734-1140
2299-5684
2299-5684
DOI:10.1016/S1734-1140(12)70739-9